We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

48 hedge funds and large institutions have $182M invested in Dianthus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2.44% more ownership

Funds ownership: 0% → 2.44% (+2.4%)

Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AI
Alphabet Inc
California
+$47.1M
2
EAM
Eventide Asset Management
Massachusetts
+$31.6M
3
CC
Casdin Capital
New York
+$28.7M
4
EC
EcoR1 Capital
California
+$21.7M
5
Fidelity International
Fidelity International
Bermuda
+$11.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
26
HBK Investments
Texas
$338K +$353K +1,563 New
NIP
27
Nicholas Investment Partners
California
$280K +$293K +1,298 New
Deutsche Bank
28
Deutsche Bank
Germany
$270K +$282K +1,250 New
Blackstone Inc
29
Blackstone Inc
New York
$236K +$247K +1,094 New
CIBC Private Wealth Group
30
CIBC Private Wealth Group
Georgia
$215K +$224K +994 New
Northern Trust
31
Northern Trust
Illinois
$179K +$187K +829 New
MWNA
32
Marshall Wace North America
New York
$135K +$141K +625 New
SSA
33
Schonfeld Strategic Advisors
New York
$135K +$141K +625 New
Tudor Investment Corp
34
Tudor Investment Corp
Connecticut
$135K +$141K +625 New
TAM
35
Tiverton Asset Management
Delaware
$125K +$131K +579 New
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$109K +$114K +506 New
PHK
37
Point72 Hong Kong
Hong Kong
$109K +$114K +506 New
GHCM
38
Glen Harbor Capital Management
California
$63K +$66.1K +293 New
MCIM
39
Meadow Creek Investment Management
Georgia
$52K +$54.6K +242 New
EP
40
Elkfork Partners
Oregon
$41K +$42.9K +190 New
TAM
41
Tyers Asset Management
Texas
$30K +$31.1K +138 New
MSA
42
Marino Stram & Associates
Massachusetts
$22K – – –
UBS Group
43
UBS Group
Switzerland
$15K +$15.8K +70 New
SWM
44
SeaCrest Wealth Management
New York
$14K +$14.2K +63 New
RCM
45
Riverhead Capital Management
Delaware
$10K +$10.4K +46 New
CSS
46
Cubist Systematic Strategies
Connecticut
$10K +$10.6K +47 New
Morgan Stanley
47
Morgan Stanley
New York
$7K +$7K +31 New
VFA
48
Valeo Financial Advisors
Indiana
$6K +$7K +31 New
CCA
49
Catalyst Capital Advisors
New York
$5K +$5.42K +24 New
TDC
50
Thompson Davis & Co
Virginia
$4K +$4.51K +20 New
1
2

DNTH Hedge Fund Activity: Q2 2018 in Review

48 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Dianthus Therapeutics (DNTH) for Q2 2018, worth a combined $182M.

Buyers outnumbered sellers: 48 funds opened new DNTH positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Alphabet Inc, opening a new position worth an estimated $47.1M.

  • 48 institutional investors held Dianthus Therapeutics (DNTH) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $182M of Dianthus Therapeutics stock for Q2 2018.
  • 48 funds opened new Dianthus Therapeutics positions in Q2 2018 and 0 closed out, a net change of +48 holders.
  • The largest Dianthus Therapeutics buyer in Q2 2018 was Alphabet Inc, an estimated $47.1M added.

Based on aggregated 13F filings for Q2 2018.